Generation Bio Co (GBIO)

05:45 AM

Generation Bio Co. (NASDAQ:GBIO) Shares Purchased by Barclays PLC - Defense World

05:45 AM

Jan 20, 2025

Generation Bio chief scientific officer Matthew Stanton to leave role - MSN

Jan 20, 2025

Jan 18, 2025

Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace

Jan 18, 2025

Jan 17, 2025

Analysts Provide Insight Into Generation Bio Co’s (GBIO) Potential. - Stocks Register

Jan 17, 2025

Jan 16, 2025

Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely? - Yahoo Finance

Jan 16, 2025

Jan 16, 2025

Generation Bio Independent Director Acquires 131% More Stock - Yahoo Finance

Jan 16, 2025

Jan 15, 2025

Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa

Jan 14, 2025

Jan 14, 2025

Generation Bio Co. (NASDAQ:GBIO) Director Anthony G. Quinn Purchases 125,791 Shares - MarketBeat

Jan 14, 2025

Jan 14, 2025

Anthony G. Quinn Purchases 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat

Jan 14, 2025

Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares - Investing.com

Jan 14, 2025

Jan 14, 2025

Seattle immunotherapy startup Umoja Biopharma raises $100M - GeekWire

Jan 14, 2025

Jan 11, 2025

Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat

Jan 11, 2025

Jan 10, 2025

Needham & Company LLC Issues Pessimistic Forecast for Generation Bio (NASDAQ:GBIO) Stock Price - Defense World

Jan 10, 2025

Jan 09, 2025

Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock - Investing.com Canada

Jan 09, 2025

Jan 09, 2025

Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies - Business Wire

Jan 09, 2025

Jan 08, 2025

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights

Jan 08, 2025

Jan 08, 2025

Needham & Company LLC Lowers Generation Bio (NASDAQ:GBIO) Price Target to $8.00 - MarketBeat

Jan 08, 2025

Jan 07, 2025

Barclays PLC Boosts Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jan 07, 2025

Jan 07, 2025

Generation Bio Announces Executive Departures and Appointments - Defense World

Jan 07, 2025

Jan 07, 2025

Generation Bio Restructures Leadership and Focuses on siRNA - TipRanks

Jan 07, 2025

Jan 06, 2025

Generation Bio Co. Announces Executive Changes - Marketscreener.com

Jan 06, 2025

Jan 06, 2025

Generation Bio Co. to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - Marketscreener.com

Jan 06, 2025

Jan 06, 2025

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune - EIN News

Jan 06, 2025

Jan 06, 2025

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - The Manila Times

Jan 06, 2025

Jan 06, 2025

Generation Bio Pivots to Autoimmune Disease Treatment with Novel T Cell Technology - StockTitan

Jan 06, 2025

Jan 01, 2025

Generation Bio Co. (NASDAQ:GBIO) Holdings Raised by State Street Corp - Defense World

Jan 01, 2025

Dec 30, 2024

Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 16.3% in December - MarketBeat

Dec 30, 2024

Dec 25, 2024

Contrasting Spyre Therapeutics (NASDAQ:SYRE) & Generation Bio (NASDAQ:GBIO) - Defense World

Dec 25, 2024

Dec 20, 2024

Next-Generation Biomanufacturing Market Vendor and Technology Assessment Report 2024-2031 - openPR

Dec 20, 2024

Dec 18, 2024

Generation Bio stock hits 52-week low at $1.11 By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 17, 2024

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio - BioSpace

Dec 17, 2024

Dec 17, 2024

Generation Bio stock hits 52-week low at $1.11 - Investing.com

Dec 17, 2024

Dec 15, 2024

Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 15, 2024

Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles - Investing.com Australia

Dec 15, 2024

Dec 09, 2024

BB Biotech AG Reduces Stake in Generation Bio Co: An In-Depth Analysis - GuruFocus.com

Dec 09, 2024

Dec 09, 2024

“Next-Generation Bioformulations” for Plant Growth Promotion and Stress Mitigation: A Promising Approach for Sustainable Agriculture | Request PDF - ResearchGate

Dec 09, 2024

Dec 04, 2024

Molecular Diagnostics Market to grow by USD 7.92 Billion (2024-2028), driven by rising age-related diseases; Report highlights AI-driven transformationTechnavio - Lelezard

Dec 04, 2024

Dec 02, 2024

US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks - Simply Wall St

Dec 02, 2024

Dec 02, 2024

Baker BROS. Advisors LP Acquires 737,988 Shares of Generation Bio Co. (NASDAQ:GBIO) - MarketBeat

Dec 02, 2024

Nov 23, 2024

Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 21, 2024

Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks

Nov 21, 2024